Mesenchymal stem cell dysfunction in diabetes

@article{Fijany2018MesenchymalSC,
  title={Mesenchymal stem cell dysfunction in diabetes},
  author={Arman Fijany and Lohrasb R. Sayadi and Nima Khoshab and Derek A. Banyard and Ashkaun Shaterian and Michael N. Alexander and J Lakey and Keyianoosh Z. Paydar and Gregory R. D. Evans and Alan D Widgerow},
  journal={Molecular Biology Reports},
  year={2018},
  volume={46},
  pages={1459-1475}
}
Diabetes mellitus (DM) is a chronic disease that results in a variety of systemic complications. Recently, stem cell-based therapies have been proposed as potential modalities to manage DM related complications. Mesenchymal stem cell (MSC) based therapies are often considered as an ideal stem cell-based treatment for DM management due to their immunosuppressive characteristics, anti-inflammatory properties and differentiation potential. While MSCs show tremendous promise, the underlying… CONTINUE READING
4
Twitter Mentions

Citations

Publications citing this paper.

References

Publications referenced by this paper.
SHOWING 1-10 OF 113 REFERENCES